Precision Medicine May Benefit Patients with Rare Tumors bit.ly/2hW2OgY
New Guidelines Proposed for Preventing and Treating CAR T-Cell Side Effects bit.ly/2z9ZTvD
Judy Garber, MD, discusses the role of PARP inhibitors in triple-negative breast cancer. bit.ly/2iBHOjd
OncoTherapy Network retweeted
New on our site: The top 5 states to practice in 2017! @cmaphysicians @texmed @MSMA1 @ArkMedSoc @Alaska_DHSS bit.ly/2yPXTZI
Timing and Sequencing of Immunotherapies May Be Critical to Therapeutic Efficacy bit.ly/2kYojSB #Immunotherapy
Can Beta Blockers Boost the Potential of Checkpoint Inhibitors? bit.ly/2wLSDl6
Genetic Fusion Detection May Benefit NSCLC Patients bit.ly/2z1I5Ql #lungcancer
Daratumumab May Benefit Myeloma Patients Ineligible for ASCT bit.ly/2xe3AQI #MYELOMA
Breaking: Abemaciclib Receives FDA Approval for Certain Metastatic Breast Cancers bit.ly/2fFnCfn #breastcancer #FDA
Liquid Biopsies Could Help Guide Therapy in Carcinoma of Unknown Primary bit.ly/2yts3gW
Circulating Tumors Cells May Help Guide Therapy and Predict Poor Prognosis in Lung Cancer Patients bit.ly/2yCHhRu #lungcancer
Friday Image IQ: A 52-year-old woman presents with a polypoid endometrial tumor. What's your diagnosis? bit.ly/2jR8OeM
Triple Drug Approach May Halt Acute Lymphoblastic Leukemia bit.ly/2fbLaEN
1
Join the Physicians Practice TweetChat today at 12:00 PM eastern! Health care policy issues are on the agenda. #P2DocChat nitter.gq/PhysiciansPract/status…
The #P2DocChat is tomorrow! Come join us and @DrLindaMD to discuss healthcare reform. @CoherenceMed @judithconsult @JoeBabaian
CRISPR strikes again! Dozens of New Genes Associated With Cancer Treatment Resistance Are Identified. bit.ly/2jEiBET #CRISPR
Combating MYCN-Driven Leukemogenesis May Benefit AML Patients bit.ly/2eVhThd #AML
1
Precision Medicine Could Soon Be a Reality for Gastric Cancer bit.ly/2gWC2bb
OncoTherapy Network retweeted
.@US_FDA approves first gene therapy for pediatric #leukemia
goo.gl/dPqVAG #ChildhoodCancer #FDAapproves




